Stem Cell
Stem Cell
Stem Cell
Stem cells are defined as totipotent progenitor cells capable of self renewal and multilineage differentiation. Stem cells survive well and show stable division in culture, making them ideal targets for in vitro manipulation. Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are distinguished from other cell types by their capacity of renewing themselves through cell division, sometimes after long period of inactivity and under certain physiologic or experimental conditions, stem cells can be induced to become tissue- or organ-specific cells with special functions. The role of stem cells is particularly evident in the case of several types of differentiated cells, including blood cells, epithelial cells of the skin, and the epithelial cells lining the digestive tract, that have short life spans and must be replaced by continual cell proliferation in adult animals. The production of blood cells provides a good example of the role of stem cells in maintaining differentiated cell populations. All of these blood cells have limited life spans and are continually produced by the division of a pluripotent stem cell in the bone marrow (Figure-1). Descendants of the pluripotent stem cell then continue to proliferate and undergo several rounds of divisions as they differentiate.
Figure 1: Development of different types of blood cells from a pluripotent stem cell in the bone marrow
layers: ectoderm, endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell types of the adult body when given sufficient and necessary stimulation for a specific cell type. Sexual reproduction begins when a male's sperm fertilizes a female's ovum (egg) to form a single cell called a zygote. The single zygote cell then begins a series of divisions, forming 2, 4, 8, 16 cells, etc. After four to six days, before implantation in the uterus, this mass of cells is called a blastocyst. The blastocyst consists of an inner cell mass (embryoblast) and an outer cell mass (trophoblast). The outer cell mass becomes part of the placenta, and the inner cell mass is the group of cells that will differentiate to become all the structures of an adult organism. This latter mass is the source of embryonic stem cells - totipotent cells (cells with total potential to develop into any cell in the body). Nearly all research to date has made use of mouse embryonic stem cells (mES) (Figure-2) or human embryonic stem cells (hES). Both have the essential stem cell characteristics, yet they require very different environments in order to maintain an undifferentiated state. Mouse ES cells are grown on a layer of gelatin and require the presence of leukemia inhibitory factor (LIF). Human ES cells are grown on a feeder layer of mouse embryonic fibroblasts (MEFs) and require the presence of basic fibroblast growth factor (bFGF or FGF-2). ES cells, being pluripotent cells, require specific signals for correct differentiation; if injected directly into another body, ES cells will differentiate into many different types of cells, causing a teratoma.
Amniotic stem cells found in amniotic fluid are very active, expand extensively without feeders and are not tumorigenic. Amniotic stem cells are multipotent and can differentiate in cells of adipogenic, osteogenic, myogenic, endothelial, hepatic and also neuronal lines. Use of stem cells from amniotic fluid overcomes the ethical objections to using human embryos as a source of cells.
mice, pigs, cattle, goats, rabbits and cats. In therapeutic cloning, a nucleus from an adult human cell would be transferred to an oocyte, which would be used to produce an early embryo in culture. Embryonic stem cells cultured from such a cloned embryo could then, in principle, be used to generate appropriate types of differentiated cells for transplantation therapy. The possibility of such transplantation therapy offers hope for the treatment of a variety of devasting disorders, including Parkinson's disease, Alzheimer's disease, diabetes and spinal cord injuries. A number of adult stem cell therapies already exist, particularly bone marrow transplants that are used to treat leukemia.Substantial improvements are meeded in the methods used to generate embryos by nuclear transfer and it will be necessary to develop procedures that reliably differentiate embyonic stem cells into the appropriate cell types prior to transplantation. The development of therapeutic cloning also raises ethical concerns, not only with respect to possibility of cloning human beings, but also with respect to the destruction of embryos that serve as the source of embryonic stem cells. While many challenges remain, continuing research on stem cells holds great promise of opening new approaches to the treatment of a broad array of human diseases.